Mitochon
Pharmaceuticals is a biotech company that focuses on developing drugs that target the mitochondria for a host of serious diseases... Read moreMitochon
Pharmaceuticals is a biotech company that focuses on developing drugs that target the mitochondria for a host of serious diseases... Read more
News
Jun 27, 2022
Endpoints News
Mitochon: Mitochondria biotech receives Morningside buyout offer after PhII fail; Oncology microcap withdraws IPO plans
Sep 28, 2021
BioSpace
Mitochon: Mitochon Pharmaceuticals and University of Kentucky Awarded MTEC Grant for MP-201 in Traumatic Brain Injury
Mar 05, 2019
BioPortfolio
Mitochon Pharmaceuticals: Mitochon Pharmaceuticals Awarded Orphan Drug Designation
Mar 05, 2019
PT Community
Mitochon Pharmaceuticals: New Compound Gets Orphan Drug Status for Huntington's Disease
Oct 01, 2018
BioPortfolio
Mitochon Pharmaceuticals: Mitochon Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13082018 Prices from USD $250
Aug 08, 2018
BioPortfolio
Mitochon Pharmaceuticals: Mitochon Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 23042018 Prices from USD $250
Apr 14, 2018
BioPortfolio
Mitochon Pharmaceuticals: Mitochon Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13032018 Prices from USD $250
Nov 08, 2017
PharmiWeb
Mitochon Pharmaceuticals: Mitochon Pharmaceuticals Announces First Patent Allowance for Mitochondrial Targeted Therapies for Neurodegeneration
Oct 04, 2017
Center Watch
Mitochon Pharmaceuticals: Mitochon Pharmaceuticals to support mitochondrial research in Parkinson's
Sep 11, 2017
BioPortfolio
Mitochon Pharmaceuticals: Mitochon Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 23082017 Prices from USD $250
